Nuzenio

Kaigene

Kaigene news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Taisho Pharmaceutical licenses Kaigene’s KG006 for Japan autoimmune drug push - International Business TimesInternational Business Times · Fri, 31 Jul 2026 16:15:29 GMTKaigene Licenses KG006 to Taisho in Japan - Contract PharmaContract Pharma · Fri, 31 Jul 2026 12:42:07 GMTKaigene maps final territory for KG006 with Taisho deal, embedding Japan partner in global Phase III trial - AllSciAllSci · Fri, 31 Jul 2026 12:34:09 GMT'Celltrion Partner' Kaigene Licenses Autoimmune Drug to Japan's Taisho - Seoul Economic DailySeoul Economic Daily · Fri, 31 Jul 2026 05:50:35 GMTKaigene Enters into Exclusive Licensing Agreement with Taisho Pharmaceutical for Next-Generation Autoimmune Asset KG006 in Japan - PR NewswirePR Newswire · Thu, 30 Jul 2026 07:00:00 GMT

Timeline

Fri, 31 Jul 2026 16:15:29 GMTTaisho Pharmaceutical licenses Kaigene’s KG006 for Japan autoimmune drug push - International Business Times
Fri, 31 Jul 2026 12:42:07 GMTKaigene Licenses KG006 to Taisho in Japan - Contract Pharma
Fri, 31 Jul 2026 12:34:09 GMTKaigene maps final territory for KG006 with Taisho deal, embedding Japan partner in global Phase III trial - AllSci
Fri, 31 Jul 2026 05:50:35 GMT'Celltrion Partner' Kaigene Licenses Autoimmune Drug to Japan's Taisho - Seoul Economic Daily
Thu, 30 Jul 2026 07:00:00 GMTKaigene Enters into Exclusive Licensing Agreement with Taisho Pharmaceutical for Next-Generation Autoimmune Asset KG006 in Japan - PR Newswire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Kaigene.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.